{
"info": {
"nct_id": "NCT04642027",
"official_title": "PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy of Biochemical Failure After Radical Prostatectomy for Prostate Cancer",
"inclusion_criteria": "* Patients with prostate adenocarcinoma treated with radical prostatectomy;\n* Tumour stage pT2-4, R0-1, pN0, or cN0, cNx according to the UICC TNM 2009, only with Gleason score available;\n* No lymph node or distant metastases. A recent PSMA-PET scan (< 60 days) without evidence of lymph node or distant metastases;\n* PSA progression after prostatectomy defined as two consecutive rises with the final PSA > 0.1 ng/mL or 3 consecutive rises. The first value must be measured at least 6 weeks after radical prostatectomy;\n* PSA at inclusion < 1.0 ng/mL;\n* WHO performance status 0-2 at inclusion;\n* Age at inclusion between 18 and 80 years;\n* Written (signed and dated) informed consent prior to registration.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
"exclusion_criteria": "* Prior pelvic irradiation, (chemo)hormonal therapy or orchiectomy;\n* Previous or concurrent active invasive cancers other than superficial non-melanoma skin cancers;\n* Patients with positive nodes or with distant metastases based on the surgical specimen of lymphadenectomy or the following minimum diagnostic workup: PSMA-PET/CT scan, 60 days prior to registration;\n* Double-sided metallic hip prosthesis;\n* Inability or unwillingness to understand the information on trial-related topics, to give informed consent or to fill out QoL questionnaires.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with prostate adenocarcinoma treated with radical prostatectomy;",
"criterions": [
{
"exact_snippets": "prostate adenocarcinoma",
"criterion": "prostate adenocarcinoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "treated with radical prostatectomy",
"criterion": "treatment with radical prostatectomy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Tumour stage pT2-4, R0-1, pN0, or cN0, cNx according to the UICC TNM 2009, only with Gleason score available;",
"criterions": [
{
"exact_snippets": "Tumour stage pT2-4",
"criterion": "tumour stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2,
"unit": "pT"
},
{
"operator": "<=",
"value": 4,
"unit": "pT"
}
]
}
}
]
},
{
"exact_snippets": "R0-1",
"criterion": "resection margin status",
"requirements": [
{
"requirement_type": "status",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "R"
},
{
"operator": "<=",
"value": 1,
"unit": "R"
}
]
}
}
]
},
{
"exact_snippets": "pN0",
"criterion": "pathological lymph node status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "pN0"
}
]
},
{
"exact_snippets": "cN0, cNx",
"criterion": "clinical lymph node status",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"cN0",
"cNx"
]
}
]
},
{
"exact_snippets": "Gleason score available",
"criterion": "Gleason score",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
}
]
},
{
"line": "* No lymph node or distant metastases. A recent PSMA-PET scan (< 60 days) without evidence of lymph node or distant metastases;",
"criterions": [
{
"exact_snippets": "No lymph node ... without evidence of lymph node",
"criterion": "lymph node metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No ... distant metastases ... without evidence of ... distant metastases",
"criterion": "distant metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "A recent PSMA-PET scan (< 60 days)",
"criterion": "PSMA-PET scan",
"requirements": [
{
"requirement_type": "recency",
"expected_value": {
"operator": "<",
"value": 60,
"unit": "days"
}
}
]
}
]
},
{
"line": "* PSA progression after prostatectomy defined as two consecutive rises with the final PSA > 0.1 ng/mL or 3 consecutive rises. The first value must be measured at least 6 weeks after radical prostatectomy;",
"criterions": [
{
"exact_snippets": "PSA progression after prostatectomy defined as two consecutive rises with the final PSA > 0.1 ng/mL",
"criterion": "PSA progression",
"requirements": [
{
"requirement_type": "pattern",
"expected_value": "two consecutive rises"
},
{
"requirement_type": "final PSA level",
"expected_value": {
"operator": ">",
"value": 0.1,
"unit": "ng/mL"
}
}
]
},
{
"exact_snippets": "PSA progression after prostatectomy defined as ... 3 consecutive rises",
"criterion": "PSA progression",
"requirements": [
{
"requirement_type": "pattern",
"expected_value": "3 consecutive rises"
}
]
},
{
"exact_snippets": "The first value must be measured at least 6 weeks after radical prostatectomy",
"criterion": "PSA measurement timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "at least 6 weeks after radical prostatectomy"
}
]
}
]
},
{
"line": "* PSA at inclusion < 1.0 ng/mL;",
"criterions": [
{
"exact_snippets": "PSA at inclusion < 1.0 ng/mL",
"criterion": "PSA level",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 1.0,
"unit": "ng/mL"
}
}
]
}
]
},
{
"line": "* WHO performance status 0-2 at inclusion;",
"criterions": [
{
"exact_snippets": "WHO performance status 0-2",
"criterion": "WHO performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Age at inclusion between 18 and 80 years;",
"criterions": [
{
"exact_snippets": "Age at inclusion between 18 and 80 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 80,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Written (signed and dated) informed consent prior to registration.",
"criterions": [
{
"exact_snippets": "Written (signed and dated) informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "format",
"expected_value": [
"written",
"signed",
"dated"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 80 Years",
"criterions": [
{
"exact_snippets": "maximum age of 80 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 80,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Prior pelvic irradiation, (chemo)hormonal therapy or orchiectomy;",
"criterions": [
{
"exact_snippets": "Prior pelvic irradiation",
"criterion": "pelvic irradiation",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
},
{
"exact_snippets": "(chemo)hormonal therapy",
"criterion": "(chemo)hormonal therapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
},
{
"exact_snippets": "orchiectomy",
"criterion": "orchiectomy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous or concurrent active invasive cancers other than superficial non-melanoma skin cancers;",
"criterions": [
{
"exact_snippets": "Previous or concurrent active invasive cancers",
"criterion": "active invasive cancers",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "other than superficial non-melanoma skin cancers",
"criterion": "superficial non-melanoma skin cancers",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with positive nodes or with distant metastases based on the surgical specimen of lymphadenectomy or the following minimum diagnostic workup: PSMA-PET/CT scan, 60 days prior to registration;",
"criterions": [
{
"exact_snippets": "Patients with positive nodes",
"criterion": "lymph nodes",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "distant metastases based on the surgical specimen of lymphadenectomy",
"criterion": "distant metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "PSMA-PET/CT scan, 60 days prior to registration",
"criterion": "PSMA-PET/CT scan",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 60,
"unit": "days"
}
}
]
}
]
},
{
"line": "* Double-sided metallic hip prosthesis;",
"criterions": [
{
"exact_snippets": "Double-sided metallic hip prosthesis",
"criterion": "hip prosthesis",
"requirements": [
{
"requirement_type": "type",
"expected_value": "double-sided metallic"
}
]
}
]
},
{
"line": "* Inability or unwillingness to understand the information on trial-related topics, to give informed consent or to fill out QoL questionnaires.",
"criterions": [
{
"exact_snippets": "Inability or unwillingness to understand the information on trial-related topics",
"criterion": "understanding of trial-related topics",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "Inability or unwillingness ... to give informed consent",
"criterion": "ability to give informed consent",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "Inability or unwillingness ... to fill out QoL questionnaires",
"criterion": "ability to fill out QoL questionnaires",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}